29 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 29 of 29 clinical reviews.
A physician-level review of rosuvastatin use after bariatric surgery, covering absorption changes, dosing, drug interactions, and cardiovascular risk management post-RYGB and sleeve gastrectomy.
Evidence-based guide to rosuvastatin dosing in young adults aged 18 to 29, covering starting doses, titration, monitoring, fertility considerations, and when statins are actually indicated in this age group.
FDA rosuvastatin labeling in severe renal impairment (eGFR <30): start 5 mg once daily, cap at 10 mg, and the 40 mg is contraindicated, even on dialysis.
A guide to rosuvastatin safety during pregnancy and breastfeeding, covering FDA labeling, the biological rationale for the contraindication, what the limited human exposure data show, and what to do if you took Crestor before knowing you were pregnant.
Evidence-based guide to rosuvastatin safety in geriatric patients, covering dose adjustments, renal considerations, myopathy risk, drug interactions, and deprescribing strategies for adults 65+.
A guide to rosuvastatin safety for adults aged 30 to 49, covering side effects, monitoring, muscle risk, liver enzymes, drug interactions, and long-term outcomes from JUPITER and other trials.
Does rosuvastatin (Crestor) change appetite or food cravings? A primary-literature analysis covering mechanisms, clinical trial data, patient reports, and what to do if you notice changes.
A comprehensive clinical review of rosuvastatin (Crestor) use in patients with autoimmune conditions, covering statin-induced myopathy, SIAM, lupus interactions, immunomodulatory effects, and practical prescribing guidance.
A clinical review of rosuvastatin (Crestor) and its effects on bone mineral density, fracture risk, and osteoblast activity, with primary-literature citations and dosing context.
Evidence-based guide to rosuvastatin (Crestor) dosing in adults 65 and older, covering starting doses, renal adjustments, drug interactions, deprescribing, and safety monitoring.
A guide to rosuvastatin (Crestor) hair loss and skin side effects, including incidence data, mechanisms, management, and when to call your prescriber.
A clinical history of rosuvastatin (Crestor), from Shionogi's discovery through FDA approval, the JUPITER trial, and generic availability. Includes mechanism of action, key trials, and development timeline.
A deep dive into how rosuvastatin (Crestor) affects liver enzymes, hepatotoxicity risk, ALT/AST monitoring, and when dose adjustments are needed. Backed by JUPITER trial data and current ACC/AHA guidelines.
A physician-level breakdown of how rosuvastatin (Crestor) works, from HMG-CoA reductase inhibition through LDL receptor upregulation, pleiotropic anti-inflammatory effects, and clinical outcomes in trials like JUPITER and METEOR.
A thorough clinical review of rosuvastatin (Crestor) and its mental health and mood effects, covering trial data, pharmacology, FDA labeling, and what patients and prescribers need to know.
Crestor (rosuvastatin) has a half-life of about 19 hours, so it can be taken any time of day. Steady state is reached in roughly 5 days of daily dosing.
A clinician-level guide to the rosuvastatin pre-surgery hold window, covering ACC/AHA guideline recommendations, JUPITER trial data, perioperative statin evidence, and practical dosing decisions for patients on Crestor.
Complete regulatory history of rosuvastatin (Crestor) across the US, EU, Canada, and UK, including original approvals, generic availability, label expansions, and current prescribing status.
A clinical review of rosuvastatin (Crestor) safety signals, FDA regulatory actions, post-marketing surveillance data, and what prescribers and patients need to know about statin risk.
A clinician-level review of how rosuvastatin (Crestor) affects sleep architecture, including REM suppression data, proposed mechanisms, and practical dosing guidance to minimize sleep disruption.
How to store rosuvastatin (Crestor) correctly, what degrades the tablet, and how long it remains potent. FDA label data, ICH stability testing, and real-world pharmacist guidance.
A week-by-week guide to what happens during your first month on Crestor (rosuvastatin): LDL changes, side effects, lab timing, and when to call your doctor.
Evidence-based guide to rosuvastatin food and supplement interactions, including grapefruit, CoQ10, red yeast rice, fiber, antacids, and herbal products. with PubMed citations.
Why rosuvastatin still has drug interactions, with exact combination-specific actions from the April 2026 US CRESTOR label and study limits.
Rosuvastatin (Crestor) is a once-daily statin, 5-40 mg, with a 19-hour half-life. Miss a dose? Take it the same day, skip it the next day, never double.
A clinician-grade review of rosuvastatin (Crestor) off-label uses, from primary prevention in elevated hsCRP to contrast nephropathy prophylaxis, graded by trial evidence.
Took extra rosuvastatin? Find emergency steps, what to tell Poison Control, and how to record the dose and get advice about your next scheduled tablet.
What three studies can—and cannot—tell you about stopping rosuvastatin, from early LDL changes to cardiovascular outcomes and muscle symptoms.
Evidence-based protocols for switching between rosuvastatin and other statins, including dose equivalence tables, monitoring timelines, and clinical considerations for safe transitions.